Andexanet Alfa Should Be Used to Reverse Factor Xa Inhibitors in the Setting of Life-Threatening Bleeding

Ann Emerg Med. 2023 Sep;82(3):364-365. doi: 10.1016/j.annemergmed.2022.11.022. Epub 2023 Jan 19.
No abstract available

MeSH terms

  • Anticoagulants / adverse effects
  • Factor Xa / therapeutic use
  • Factor Xa Inhibitors* / adverse effects
  • Hemorrhage* / chemically induced
  • Hemorrhage* / drug therapy
  • Humans
  • Recombinant Proteins / therapeutic use

Substances

  • Factor Xa Inhibitors
  • PRT064445
  • Factor Xa
  • Recombinant Proteins
  • Anticoagulants